SPINEGUARD SA (ALSGD.PA) Stock Fundamental Analysis
Europe - EPA:ALSGD - FR0011464452 - Common Stock
0.109 EUR
-0.01 (-5.22%)
Taking everything into account, ALSGD scores 1 out of 10 in our fundamental rating. ALSGD was compared to 62 industry peers in the Health Care Equipment & Supplies industry. ALSGD has a bad profitability rating. Also its financial health evaluation is rather negative. ALSGD has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year ALSGD has reported negative net income.
In the past year ALSGD has reported a negative cash flow from operations.
In the past 5 years ALSGD always reported negative net income.
ALSGD had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ALSGD has a Return On Assets of -30.69%. This is amonst the worse of the industry: ALSGD underperforms 83.87% of its industry peers.
ALSGD's Return On Equity of -59.82% is on the low side compared to the rest of the industry. ALSGD is outperformed by 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.69% | ||
| ROE | -59.82% | ||
| ROIC | N/A |
ROA(3y)-32.05%
ROA(5y)-28.87%
ROE(3y)-64.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 70.98%, ALSGD belongs to the best of the industry, outperforming 82.26% of the companies in the same industry.
ALSGD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALSGD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y-2.09%
2. Health
2.1 Basic Checks
ALSGD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALSGD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALSGD has more shares outstanding
The debt/assets ratio for ALSGD is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -3.62, we must say that ALSGD is in the distress zone and has some risk of bankruptcy.
ALSGD has a Altman-Z score of -3.62. This is amonst the worse of the industry: ALSGD underperforms 91.94% of its industry peers.
ALSGD has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
ALSGD has a Debt to Equity ratio (0.34) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.62 |
ROIC/WACCN/A
WACC8.52%
2.3 Liquidity
ALSGD has a Current Ratio of 1.07. This is a normal value and indicates that ALSGD is financially healthy and should not expect problems in meeting its short term obligations.
ALSGD's Current ratio of 1.07 is on the low side compared to the rest of the industry. ALSGD is outperformed by 77.42% of its industry peers.
A Quick Ratio of 0.82 indicates that ALSGD may have some problems paying its short term obligations.
ALSGD has a Quick ratio of 0.82. This is in the lower half of the industry: ALSGD underperforms 66.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
ALSGD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.66%, which is quite impressive.
ALSGD shows a decrease in Revenue. In the last year, the revenue decreased by -4.47%.
ALSGD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.41% yearly.
EPS 1Y (TTM)47.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.37%
Revenue 1Y (TTM)-4.47%
Revenue growth 3Y1.8%
Revenue growth 5Y-7.41%
Sales Q2Q%-13.31%
3.2 Future
The Earnings Per Share is expected to grow by 29.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALSGD will show a small growth in Revenue. The Revenue will grow by 1.70% on average per year.
EPS Next Y83.22%
EPS Next 2Y35.36%
EPS Next 3Y29.42%
EPS Next 5YN/A
Revenue Next Year-15.4%
Revenue Next 2Y-7.32%
Revenue Next 3Y1.7%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ALSGD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSGD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ALSGD's earnings are expected to grow with 29.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.36%
EPS Next 3Y29.42%
5. Dividend
5.1 Amount
No dividends for ALSGD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALSGD (10/30/2025, 7:00:00 PM)
0.109
-0.01 (-5.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.87M
Revenue(TTM)4.32M
Net Income(TTM)-2562600
Analysts84.44
Price Target0.64 (487.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)79.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.59 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.6 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.07
BVpS0.07
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.69% | ||
| ROE | -59.82% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.98% | ||
| FCFM | N/A |
ROA(3y)-32.05%
ROA(5y)-28.87%
ROE(3y)-64.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y-2.09%
F-Score4
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 73.97% | ||
| Cap/Sales | 5.92% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | -3.62 |
F-Score4
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)225.04%
Cap/Depr(5y)170.18%
Cap/Sales(3y)14.39%
Cap/Sales(5y)11.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.37%
EPS Next Y83.22%
EPS Next 2Y35.36%
EPS Next 3Y29.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.47%
Revenue growth 3Y1.8%
Revenue growth 5Y-7.41%
Sales Q2Q%-13.31%
Revenue Next Year-15.4%
Revenue Next 2Y-7.32%
Revenue Next 3Y1.7%
Revenue Next 5YN/A
EBIT growth 1Y43.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.56%
EBIT Next 3Y31.68%
EBIT Next 5YN/A
FCF growth 1Y65.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y67.57%
OCF growth 3YN/A
OCF growth 5YN/A
SPINEGUARD SA / ALSGD.PA FAQ
Can you provide the ChartMill fundamental rating for SPINEGUARD SA?
ChartMill assigns a fundamental rating of 1 / 10 to ALSGD.PA.
Can you provide the valuation status for SPINEGUARD SA?
ChartMill assigns a valuation rating of 1 / 10 to SPINEGUARD SA (ALSGD.PA). This can be considered as Overvalued.
Can you provide the profitability details for SPINEGUARD SA?
SPINEGUARD SA (ALSGD.PA) has a profitability rating of 1 / 10.
How financially healthy is SPINEGUARD SA?
The financial health rating of SPINEGUARD SA (ALSGD.PA) is 1 / 10.
What is the expected EPS growth for SPINEGUARD SA (ALSGD.PA) stock?
The Earnings per Share (EPS) of SPINEGUARD SA (ALSGD.PA) is expected to grow by 83.22% in the next year.